Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Johnson and Johnson
Pharmaceuticals
GSK
AstraZeneca
Pfizer
Novo Nordisk
Roche
Novartis
Eli Lilly
Zoetis
Topics

Advertisement

Johnson and Johnson

Share

Top Latest Popular

In the last 2 hours

J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline Pharmaceutical Business Review 11:23

In the last 4 hours

J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology 09:48

In the last 6 hours

Johnson & Johnson Update: Wave 4 Correction May Be Nearing Completion After Wave 3 Extension Barchart 08:58

Advertisement

Advertisement

Yesterday

Johnson & Johnson Paying $1B For Oncology Startup Firefly Law360 21:31 Mon, 08 Jun

J&J lights up $1bn offer for pan-KRAS developer Firefly pharmaphorum 14:49 Mon, 08 Jun

STAT Plus: J&J spends $1 billion to enter KRAS race for cancer treatments STAT 14:27 Mon, 08 Jun

J&J to buy cancer drug technology developer Firefly Bio for $1 billion Rock Hill Herald 13:39 Mon, 08 Jun

Johnson & Johnson to buy Firefly Bio for $1 billion Rock Hill Herald 13:29 Mon, 08 Jun

Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform Business Wire (Press Release) 13:08 Mon, 08 Jun

Johnson & Johnson beats talc lawsuit in California court case cosmeticsbusiness.com 12:23 Mon, 08 Jun

Will Late-Stage Immunology and Oncology Wins Redefine Johnson & Johnson's (JNJ) Post-Biosimilar Narrative? Simply Wall St 10:27 Mon, 08 Jun

Saturday

Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock The Motley Fool 15:33 Sat, 06 Jun

Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer The Economic Times 02:17 Sat, 06 Jun

Johnson & Johnson Scores Defense Verdict in 2nd Talc Bellwether in Los Angeles Superior Court Law.com 01:17 Sat, 06 Jun

BREAKING: J&J Cleared Of Talc Liability In LA Bellwether Trial Law360 00:30 Sat, 06 Jun

Advertisement

Friday

J&J beats lawsuit alleging that talc caused three women's cancer The News Tribune, Washington 23:34 Fri, 05 Jun

No 'Conspiracy To Hide Asbestos' In Talc, J&J Atty Tells Jury Law360 03:07 Fri, 05 Jun

Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak is Money' Law.com 01:32 Fri, 05 Jun

Thursday

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider Zacks 23:47 Thu, 04 Jun

Johnson And Johnson Autoimmune Trial Data And What It Means For JNJ Simply Wall St 14:19 Thu, 04 Jun

EULAR 26 hears of treatment advances in lupus pharmaphorum 12:46 Thu, 04 Jun

CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus PR Newswire (Press Release) 11:40 Thu, 04 Jun

Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity PharmaTimes 11:18 Thu, 04 Jun

J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study Hospital Management 10:17 Thu, 04 Jun

J&J Innovative Medicine Korea wins reimbursement for Darzalex SC regimen in newly diagnosed AL amyloidosis Korea Biomedical Review 06:09 Thu, 04 Jun

'This Is Their Document': Jury Told J&J Docs Prove Talc Lies Law360 02:30 Thu, 04 Jun

Wednesday

Paul Hastings Settles With J&J Unit in Bankruptcy Fee Dispute Bloomberg Law 19:38 Wed, 03 Jun

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks 15:00 Wed, 03 Jun

The Expanding Frontier of Chemical Engineering: ChemE Show 2026 Opens June 9-10 in Houston PR Newswire (Press Release) 13:50 Wed, 03 Jun

A Look At Johnson & Johnson (JNJ) Valuation After Recent Share Price Weakness Simply Wall St 06:17 Wed, 03 Jun

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study PR Newswire (Press Release) 05:08 Wed, 03 Jun

Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease PR Newswire (Press Release) 05:08 Wed, 03 Jun

Talc Tester Says J&J Never Pressured Him To Hide Asbestos Law360 02:36 Wed, 03 Jun

In the last month

Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic The Motley Fool 19:58 Tue, 02 Jun

J&J’s Erleada prostate cancer study shows significant reduction in risk of metastasis PMLiVE 12:59 Tue, 02 Jun

Ga. Panel Says New Trial Warranted In J&J Talc Cancer Suit Law360 01:47 Tue, 02 Jun

ASCO26: key readouts in lung cancer Clinical Trials Arena 16:16 Mon, 01 Jun

J&J Drug Reduces Prostate Cancer Progression NewsMax 13:41 Mon, 01 Jun

ASCO26: BMS and J&J debut shining multiple myeloma data Clinical Trials Arena 12:11 Mon, 01 Jun

Rybrevant Faspro™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited PR Newswire (Press Release) 13:37 Sun, 31 May

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis